Drug intelligence / Profile preview

Ket10

Development stage: Unknown
Administration: Intravenous, Intramuscular, Intranasal, Subcutaneous, Oral, Sublingual, Rectal, Transdermal, Epidural, Intrathecal, Inhalation

Overview

Ket10 is a code name used in scientific studies to refer to a 10 mg/kg dose of a drug. In the provided context, this code has been applied to ketoconazole, an antifungal agent with prophylactic antimalarial activity, and ketamine, an N-methyl-D-aspartate (NMDA) receptor antagonist known for its antidepressant, antinociceptive, and anti-inflammatory effects. Given its application to different active pharmaceutical ingredients, 'Ket10' serves as a non-specific identifier for a dosage rather than a unique drug entity.

Beyond the preview

Go deeper on Ket10.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ket10.

Explore the full profile